December 23, 2010

The Food and Drug Administration on Wednesday approved Novartis Pharmaceuticals’ Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure, according to the pharma company.

December 1, 2010

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

November 21, 2010

A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes...

October 25, 2010

Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a...

September 28, 2010

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

September 22, 2010

Drug makers Abbott and Reata Pharmaceuticals have signed an agreement concerning a drug for chronic...

August 5, 2010

Drug maker Mission Pharmacal has launched a treatment for urinary tract infections....

July 12, 2010

Generic drug maker Watson Pharmaceuticals hopes to be the first to market a version of...

July 5, 2010

Generic drug maker Impax Labs is challenging the patent on a drug used to treat...

June 30, 2010

Lake Consumer Products on Wednesday announced its purchase of Consumer Choice Systems. The acquisition adds...

June 28, 2010

A recent study being published in the journal Urology found that Proantinox, a proprietary cranberry-based...

May 5, 2010

A Forest Labs drug used to treat mild to moderate hypertension “significantly” reduced blood pressure...

May 5, 2010

Keryx Biopharmaceuticals has started a late-stage clinical trial of a drug for patients on kidney...

February 1, 2010

Tiny areas of brain damage caused by injury to small blood vessels can signal an...